Comparison of Pharmacodynamics and Pharmacokinetics of Biphasic Insulin Aspart 50 to Biphasic Insulin Aspart 70 in Type 2 Diabetes

Mise à jour : Il y a 4 ans
Référence : NCT00612599

Femme et Homme

  • | Pays :
  • Denmark
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

This trial is conducted in Europe. The aim of this trial is to compare the pharmacodynamics and pharmacokinetics of biphasic insulin aspart 50 three times a day to biphasic insulin aspart 70 three times a day in non-obese and obese with type 2 diabetes.


Critère d'inclusion

  • diabetes ,Diabetes Mellitus, Type 2

Liens